therapy

Even so, the results open promising new avenues for therapy.

The findings could lead to safer and more precise pain therapies that avoid the risks of opioid-based treatments.

The findings explain how a crucial genetic mutation drives inflammation and could guide the development of new therapies aimed at restoring the lost partnership between girdin and NOD2.

It also compares leading laboratory methods for producing high-quality neurons, advancing efforts to develop new therapies for Parkinson's disease and other brain disorders.

A Biologics License Application, or BLA, is a formal request to the FDA to market a distribute a biological product, such as a gene therapy.